Healthcare Re-imagined
Healthcare Re-imaginedReinaldo GarciaPresident & CEOGE Healthcare - InternationalGE Healthcare 17B global business unit of GE 1B /year in R&D investment45,000 employees worldwideCore strengths in Bio-Sciences,Technology, ServicesGE heritage for vision andexecution
GE HealthcareBroad Based DiagnosticsDiagnostic ImagingMedical DiagnosticsClinical SystemsInformation Technology & ServicesLife SciencesTouching many aspects of healthcare Genomics sis from atom to body
Molecular medicine: the right next stepSensitivity& specificityEfficiencyMolecular imaging (2000 )Biology, Nanotech, CADDigital (80’s to 90’s)CT, MR, PACSAnalog (00 to 80’s)X-ray & PaperClinical certaintyHealthcare re-imaginedWe strive to see life more clearly. Our Purpose is tohelp predict, diagnose, treat and monitor disease earlier sopeople can live life to the fullestFrom "Late Disease"Symptom BasedIncomplete DataManaging IllnessStandardized treatmentTo "Early Health"Prevention/PredictionDetailed Patient InfoEarly DiagnosisTargeted TherapiesDriving clinical efficacy & Healthcare system efficiency
Globalization GrowthAcceleratorHistorical growth and trends( B)International vs. USInternational ing 1715%AGRClinicalUltrasound13Life Sciences9 7‘00ServiceMedical Diagnostics 7B International Sales Emerging countries Growth Platform‘02‘04‘06E China10-15% MEA20-25% India15-20% EE15-20% SEA20-25% LA10-15%
GE Healthcare global presenceUSAEurope & MEAAsia21,277 / 46%Employees14,970 / 32%Employees7,994 / 657Norway1,410Finland931MEA259Eastern Europe 478Americas2,168 / 5%EmployeesL America 1,504Canada6645 YrV% 50%ChinaIndiaJapanKoreaANZSEA 100 %2,9502,1221,859394382287 50%Strong global commitmentGrowth in developed markets( in Billions)JapanWestern Europe6%AGR 1.2 3.419%AGR 1.2 0.8‘00‘06E‘00‘06EKey driversKey drivers Reimbursements High End CT/MR Hospital consolidation & privatization IT investment trends & shift to digital PPP momentum in UK, Portugal, Germany & Italy EU focus on underperforming regions IT Big growth areaWinning positionContinued momentum Enterprise & Specialization . DIC’s, Cardio andWomen’s Health Strong combination of portfolio, services & coverage Segmentation & Commercial Excellence Creating markets Cardiac NM & screening Strong Services through NPS & Segmentation
Emerging markets growth engines( in Millions)IndiaChina 180 70015%AGR10%AGR 400 80‘00‘06E‘00Key Drivers‘06EKey Drivers Strong economy, plus gov’t spend up Gov’t spending in near term Public / Private Partnerships Health insurance coverage: 25% to 80% by 2010 Unmet needs in burgeoning population Value segment growthA Unique positionStrong Opportunities for GE Healthcare High-end & value products strategy Creating markets private initiatives Localization Commercial financing programs In-house financing solution Driving rural health thru local gov’t partnershipsMore emerging markets more growth( in Millions)Eastern Europe 300MEA20%AGR 40025%AGR 100 100Key Drivers‘00Key Drivers Privatization & Insurance EU Structural Funds Growing economy Oil & Gas in Russia / CIS Oil price drives infrastructure investment Expansion of private sector Shortage of qualified professionalsWinning StrategyWinning strategy Focused Regional Segmentation Company to country Financing Localization Distribution, Training & Manufacturing Company to country Strategic equity & financing participation‘00‘06E‘06E
Technology localizationLCC Technical Capability 218204076234310950Total6281,26444ChinaIndia Driving local value product16 Growing marketing effort’02Remote R&F Loqicbook Local national leadership# of NPI’s’06ESuper Value Rad Dash2500 CTe/CTe DualHF Advantage Value MRStrategyAssemblyMR Image AnalysisGlass tubesTablesMonitoringMDx Clinical TrialsSW bug fixes User I/F SW Metal TubesMaternal Infant CareHCC LCC Xfers Analog Rad/RF C-ArmsPerm MagnetAnesthesiaMfg SKDsUltrasoundCT/e xferGeneratorsICFC, IIFILow Cost Dig Rad‘96’98’00’02’04’06ComponentsMFG R&DFull Systems’08Healthcare spending & growthHealthcare spend % of GDPConvergence Band9-11%Huge Healthcare Needs population w/o access to Healthcare Undeveloped Healthcare Infrastructure Financing needs access to funding5%DevelopedDevelopingEmerging Markets TechnologySegment growth5XPrivatization trends EntrepreneursNew Infrastructure investmentsValue technologiesLoans and grants Company to CountryConcessional Loans & SKD’sFinancing & Equity investmentsRural Health 40B 8B‘05Emerging Growth Drivers ’20FGo Big GE Opportunities
Company to country in emerging marketsMarket developmentCreating demand MOH––––IdeasProjectsProviding solutionsCapability6.0, cap mkts,HFS, int’l aidFinancingCountry managementMarket developmentTech & clinical expertiseProject mgt. & turnkeyAccelerating Deal Pipeline ( MM)and 600Namibia projectSKD’sAccess tofund markets 15MM Soft loan Finland to Namibia Health issues assessment with Namibia MOH Needs identified in OR, intensive care, maternal/infant care 400 220 100 64‘05 83‘06PipelineBosnia projectOrders Soft loan Korea to Bosnia With Bosnia MOH Equipment 7 Hospitals‘07 14MMOnly GE Healthcare( in Billions) 17Revenue 15Unique Capability 3.2 The only wing to wing diagnostics companyOp Profit 2.7 Leadership across product lines Real scale R&D 1B , global reach,broadest distribution Globalization growth accelerator‘05’06EHealthcare re-imagined
Healthcare Re-imagined ReinaldoGarcia President & CEO GE Healthcare -International GE Healthcare 17B global business unit of GE 1B /year in R&D investment 45,000 employees worldwide Core strengths in Bio-Sciences, Technology, Services GE heritage for vision and execution
GE Healthcare ULTC-0236-05.09-EN-US Healthcare Re-imagined GE is dedicated to helping you transform healthcare delivery by driving critical breakthroughs in biology and technology. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, and
Healthcare Re-imagined GE is dedicated to helping you transform healthcare delivery by driving critical breakthroughs in biology and technology. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, and biopharmaceutical manufacturing technologies is
1 Introduction Ernest Gellner had said, ―Nationalism is not the awakening of nations to self-consciousness: it invents nations where they do not exist‖.1 Partly influenced by the words of Gellner, Benedict Anderson's Imagined Communities extends the discussion of ―nation‖ as a social construct, with nation defined as ―an imagined political community—and imagined as both .
imagination at work Healthcare Re-imagined GEisdedicatedtohelpingyoutransformhealthcare deliverybydrivingcriticalbreakthroughsinbiology andtechnology .
makers in healthcare management. 2 / 2022 Media Kit / ache.org The American College of Healthcare Executives is an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems and other healthcare organizations. Healthcare Executive e-TOC Published bimonthly, e-TOC is a
Function 1: Develop recovery processes for the healthcare delivery system 12 P1. Healthcare recovery planning 12 P2. Assessment of healthcare delivery recovery needs post disaster 13 P3. Healthcare organization recovery assistance and participation 13 Function 2: Assist healthcare organizations to implement Continuity of Operations (COOP) 13 P1.
healthcare industry through local support initiatives like GS1 Healthcare US in the United States. About GS1 Healthcare US GS1 Healthcare US is an industry group that focuses on driving the adoption and implementation of GS1 Standards in the healthcare industry in the United States to help improve patient safety and supply chain efficiency.
The Dissident Daughter chronicles Sue’s process as she re-writes this narrative, and she maps the journey in four stages, shown here only in the most cursory of summaries: the recognition of a “feminine wound” and her struggle to conceive a “feminine self” (Part One: Awakening); her introduction to the
